Atlas Trials

A Randomised Controlled Platform Trial Testing Treatments in Metastatic Hormone Sensitive Prostate Cancer

Clinical trial NCT06320067 · RECRUITING

Trial details

NCT number
NCT06320067
Sponsor
University College, London
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Prostate Cancer Metastatic
Start date
2024-06-11
Primary completion
2031-04-01
Enrollment
3360

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.